» Articles » PMID: 25495228

Natural Attack Rate of Influenza in Unvaccinated Children and Adults: a Meta-regression Analysis

Overview
Journal BMC Infect Dis
Publisher Biomed Central
Date 2014 Dec 16
PMID 25495228
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The natural (i.e. unvaccinated population) attack rate of an infectious disease is an important parameter required for understanding disease transmission. As such, it is an input parameter in infectious disease mathematical models. Influenza is an infectious disease that poses a major health concern worldwide and the natural attack rate of this disease is crucial in determining the effectiveness and cost-effectiveness of public health interventions and informing surveillance program design. We estimated age-stratified, strain-specific natural attack rates of laboratory-confirmed influenza in unvaccinated individuals.

Methods: Utilizing an existing systematic review, we calculated the attack rates in the trial placebo arms using a random effects model and a meta-regression analysis (GSK study identifier: 117102).

Results: This post-hoc analysis included 34 RCTs (Randomized Control Trials) contributing to 47 influenza seasons from 1970 to 2009. Meta-regression analyses showed that age and type of influenza were important covariates. The attack rates (95% CI (Confidence Interval)) in adults for all influenza, type A and type B were 3.50% (2.30%, 4.60%), 2.32% (1.47%, 3.17%) and 0.59% (0.28%, 0.91%) respectively. For children, they were 15.20% (11.40%, 18.90%), 12.27% (8.56%, 15.97%) and 5.50% (3.49%, 7.51%) respectively.

Conclusions: This analysis demonstrated that unvaccinated children have considerably higher exposure risk than adults and influenza A can cause more disease than influenza B. Moreover, a higher ratio of influenza B:A in children than adults was observed. This study provides a new, stratified and up to-date natural attack rates that can be used in influenza infectious disease models and are consistent with previous published work in the field.

Citing Articles

Reconstructed influenza A/H3N2 infection histories reveal variation in incidence and antibody dynamics over the life course.

Hay J, Zhu H, Jiang C, Kwok K, Shen R, Kucharski A PLoS Biol. 2024; 22(11):e3002864.

PMID: 39509444 PMC: 11542844. DOI: 10.1371/journal.pbio.3002864.


Wastewater Surveillance to Confirm Differences in Influenza A Infection between Michigan, USA, and Ontario, Canada, September 2022-March 2023.

Corchis-Scott R, Beach M, Geng Q, Podadera A, Corchis-Scott O, Norton J Emerg Infect Dis. 2024; 30(8):1580-1588.

PMID: 39043398 PMC: 11286066. DOI: 10.3201/eid3008.240225.


A Randomized, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of VIR-2482 in Healthy Adults for Prevention of Influenza A Illness (PENINSULA).

Tan S, Cebrik D, Plotnik D, Agostini M, Boundy K, Hebner C Clin Infect Dis. 2024; 79(4):1054-1061.

PMID: 39036981 PMC: 11478579. DOI: 10.1093/cid/ciae368.


A noninferiority randomized open-label pilot study of 3- versus 7-day influenza postexposure prophylaxis with oseltamivir in hospitalized children.

Wrotek A, Jackowska T Sci Rep. 2024; 14(1):14192.

PMID: 38902383 PMC: 11189916. DOI: 10.1038/s41598-024-65244-5.


Reconstructed influenza A/H3N2 infection histories reveal variation in incidence and antibody dynamics over the life course.

Hay J, Zhu H, Jiang C, Kwok K, Shen R, Kucharski A medRxiv. 2024; .

PMID: 38562868 PMC: 10984066. DOI: 10.1101/2024.03.18.24304371.


References
1.
Hay A, Gregory V, Douglas A, Lin Y . The evolution of human influenza viruses. Philos Trans R Soc Lond B Biol Sci. 2002; 356(1416):1861-70. PMC: 1088562. DOI: 10.1098/rstb.2001.0999. View

2.
Tricco A, Chit A, Soobiah C, Hallett D, Meier G, Chen M . Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis. BMC Med. 2013; 11:153. PMC: 3706345. DOI: 10.1186/1741-7015-11-153. View

3.
Turner D, Wailoo A, Nicholson K, Cooper N, Sutton A, Abrams K . Systematic review and economic decision modelling for the prevention and treatment of influenza A and B. Health Technol Assess. 2003; 7(35):iii-iv, xi-xiii, 1-170. DOI: 10.3310/hta7350. View

4.
Molinari N, Ortega-Sanchez I, Messonnier M, Thompson W, Wortley P, Weintraub E . The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine. 2007; 25(27):5086-96. DOI: 10.1016/j.vaccine.2007.03.046. View

5.
Mossong J, Hens N, Jit M, Beutels P, Auranen K, Mikolajczyk R . Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med. 2008; 5(3):e74. PMC: 2270306. DOI: 10.1371/journal.pmed.0050074. View